Systolic blood pressure control after participation in a hypertension intervention study

American Journal of Managed Care

Volumn 17, Issue 7, 2011, Pages 473-478

  Welch, Lesley K ^a   Olson, Kari L ^b,c   Snow, Karen E ^d   Pointer, Lauren ^a   Lambert Kerzner, Anne ^a,c   Havranek, Edward P ^c,d   Magid, David J ^c,d,e   Ho, P Michael ^a,c,d  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b Kaiser Permanente of Colorado ^*  (United States)

^c UNIVERSITY OF COLORADO   (United States)

^d DENVER HEALTH MEDICAL CENTER   (United States)

^e KAISER PERMANENTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT;

ADULT; AGED; ARTICLE; BLOOD PRESSURE MEASUREMENT; BLOOD PRESSURE REGULATION; CONTROLLED STUDY; FEMALE; HEALTH CARE PERSONNEL; HUMAN; HYPERTENSION; INTERACTIVE VOICE RESPONSE SYSTEM; MAJOR CLINICAL STUDY; MALE; PATIENT CARE; PATIENT EDUCATION; PHARMACIST; PHYSICIAN; PRIORITY JOURNAL; SYSTOLIC BLOOD PRESSURE;

ADULT; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; COHORT STUDIES; COLORADO; COMBINED MODALITY THERAPY; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERTENSION; INTERVENTION STUDIES; MALE; PROSPECTIVE STUDIES; RETROSPECTIVE STUDIES;

EID: 79960803411     PISSN: 10880224     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Lloyd-Jones D, Adams RJ, Brown TM, et al American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics - 2010 update. A report from the American Heart Association. Circulation. 2010;121(7):e46-e215.
2. Chobanian AV, Bakris GL, Black HR, et al National Heart, Lung, and Blood Institute Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure; National Heart, Lung, and Blood Institute; National High Blood Pressure Education Program Coordinating Committee. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension. 2003;42(6):1206-1252. (Pubitemid 37553153)
3. Egan BM, Zhao Y, Axon RN. US trends in prevalence, awareness, treatment, and control of hypertension, 1988-2008. JAMA. 2010;303(20): 2043-2050.
4. Mancia G, Messerli F, Bakris G, Zhou Q, Champion A, Pepine CJ. Blood pressure control and improved cardiovascular outcomes in the International Verapamil SR-Trandolapril Study. Hypertension. 2007;50(2):299-305. (Pubitemid 47205777)
5. Dolan E, Stanton AV, Thom S, et al ASCOT Investigators. Ambulatory blood pressure monitoring predicts cardiovascular events in treated hypertensive patients - an Anglo-Scandinavian cardiac outcomes trial substudy. J Hypertens. 2009;27(4):876-885.
6. Glynn LG, Murphy AW, Smith SM, Schroeder K, Fahey T. Interventions used to improve control of blood pressure in patients with hypertension. Cochrane Database Syst Rev. 2010;(3):CD005182.
7. Magid DJ, Ho PM, Olson KL, et al. A multimodal blood pressure control intervention in 3 healthcare systems. Am J Manag Care. 2011;17(4):e96-e103.
8. Carter BL, Doucette WR, Franciscus CL, Ardery G, Kluesner KM, Chrischilles EA. Deterioration of blood pressure control after discontinuation of a physician-pharmacist collaborative intervention. Pharmacotherapy. 2010;30(3):228-235.
9. Stolarz-Skrzypek K, Thijs L, Richart T, et al. Blood pressure variability in relation to outcome in the International Database of Ambulatory blood pressure in relation to Cardiovascular Outcome. Hypertens Res. 2010;33(8):757-766.
10. Burr ML, Dolan E, O'Brien EW, O'Brien ET, McCormack P. The value of ambulatory blood pressure in older adults: the Dublin outcome study. Age Ageing. 2008;37(2):201-206. (Pubitemid 351445192)
11. Stergiou GS, Kalogeropoulos PG, Baibas NM. Prognostic value of home blood pressure measurement. Blood Press Monit. 2007;12(6):391-392.
12. National Center for Health Statistics. http://www.cdc.gov/nchs/nhanes/ nhanes2009-2010/nhanes09-10.htm. Accessed July 6, 2011.
13. National Committee for Quality Assurance. http://www.ncqa.org. Accessed September 10, 2010.
14. Olson KL, Delate T, Rasmussen J, Humphries TL, Merenich JA; Clinical Pharmacy Cardiac Risk Service Study Group. Outcomes of patients discharged from pharmacy-managed cardiovascular disease management. Am J Manag Care. 2009;15(8):497-503.
15. Pearson GJ, Olson KL, Panich NE, et al. Maintenance of improved lipid levels following attendance at a cardiovascular risk reduction clinic: a 10-year experience. Vasc Health Risk Manag. 2008;4(5):1127-1135.